ESC 365 - Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160

ESC Professional Premium Access

Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160

Session: Bleeding and antiplatelet strategies in acute coronary syndromes

Topic: ST-Elevation Myocardial Infarction (STEMI)

Speaker: Doctor T. Gu (Tianjin, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tianshu Gu

2nd Hospital of Tianjin Medical University, Tianjin (China)

0 follower

7 more presentations in this session

Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry

Speaker: Doctor P. Thrane (Aarhus, DK)

Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study

Speaker: Doctor K. Miyashita (Galway, IE)

Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study

Speaker: Doctor F. Bruno (Turin, IT) Doctor F. Wenzl (Zurich, CH)

Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

Speaker: Doctor K. Keskin (Hakkari, TR) Associate Professor A. Calik (Istanbul, TR)

Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention

Speaker: Assistant Professor K. Jeon (Seongnam, KR)

Access the full session

Bleeding and antiplatelet strategies in acute coronary syndromes

Speakers: Doctor T. Gu, Doctor P. Thrane, Doctor K. Miyashita, Doctor F. Bruno, Doctor F. Wenzl...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources